Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, shared on X:
“ASTRO24 – Dr. Ohri discussed quality of life outcomes in the adaptive radiotherapy SPRINT PET ‘chemotherapy-free’ lung cancer trial.
76% PFS already reported at 1-year, and now quality of outcomes with RT and pembrolizumab
de-intensification appears favorable!”
Source: Shankar Siva/X
